PHIL Inter Pharma received the MA for the 1st product in Europe

We are glad to announce that PHIL Inter Pharma has successfully received the first Marketing Authorization
in Europe (UK and Ireland) for Ibuprofen 200 mg softgel capsule in December, 2018.

The 2nd and 3rd product, Dutasteride 0.5 mg and Ibuprofen 400 mg softgel capsules are planned to be filed
in the European countries respectively, in the first and second quarter of 2019.

Again, we are glad that we took the first step to develop the partnership with our European customers
and will do our best to further expand our portfolio for our customers.